Tomer Kariv sold $85.0M of Keros Therapeutics (KROS)

Executed Oct 15 2025, disclosed Oct 17 2025, 2 days later.

Value, as filed

$85.0M

4,787,331 sh across 4 lots

Executed

Oct 15 2025

the trade date, as filed

Disclosed

Oct 17 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

TK Tomer Kariv Director profile →

Tomer Kariv (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in KROS. The largest single filing was $85.0M of KROS (4,787,331 sh across 4 lots, as filed), executed Oct 15 2025.

The name

KROS KROS KROS · 5 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→